top of page

Withdrawn applications

Withdrawn application: Arzerra, ofatumumab: Post-authorisation:

READ MORE

Withdrawn application: Kepnetic, aceneuramic acid: Initial authorisation:

READ MORE

Withdrawn application: Graspa, eryaspase: Initial authorisation:

READ MORE

Withdrawn application: Efgratin, pegfilgrastim: Initial authorisation:

READ MORE

Withdrawn application: Cavoley, pegfilgrastim: Initial authorisation:

READ MORE

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page